FLEXERIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Flexeril, and when can generic versions of Flexeril launch?
Flexeril is a drug marketed by Janssen Res And Dev and is included in one NDA.
The generic ingredient in FLEXERIL is cyclobenzaprine hydrochloride. There are sixteen drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. Additional details are available on the cyclobenzaprine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Flexeril
A generic version of FLEXERIL was approved as cyclobenzaprine hydrochloride by ACTAVIS LABS FL INC on May 3rd, 1989.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLEXERIL?
- What are the global sales for FLEXERIL?
- What is Average Wholesale Price for FLEXERIL?
Summary for FLEXERIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 110 |
| Clinical Trials: | 9 |
| Patent Applications: | 1,249 |
| DailyMed Link: | FLEXERIL at DailyMed |
Recent Clinical Trials for FLEXERIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Augusta University | Phase 4 |
| Cognitive Research Corporation | Phase 1 |
| Neurana Pharmaceuticals, Inc. | Phase 1 |
US Patents and Regulatory Information for FLEXERIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen Res And Dev | FLEXERIL | cyclobenzaprine hydrochloride | TABLET;ORAL | 017821-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Janssen Res And Dev | FLEXERIL | cyclobenzaprine hydrochloride | TABLET;ORAL | 017821-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FLEXERIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Janssen Res And Dev | FLEXERIL | cyclobenzaprine hydrochloride | TABLET;ORAL | 017821-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Janssen Res And Dev | FLEXERIL | cyclobenzaprine hydrochloride | TABLET;ORAL | 017821-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Janssen Res And Dev | FLEXERIL | cyclobenzaprine hydrochloride | TABLET;ORAL | 017821-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
